Sign in to view content

Assessing Commercially Available Cell Therapies for Retinal Disease in the U.S.

Ajay E Kuriyan, MD, MS
Daniel Simhaee, MD

Video
Published 2018

Related

2-Year Outcomes From Randomized Trials of Anti-VEGF Treatments for Diabetic Retinopathy (DR) and Diabetic Macular Edema (DME)
Geeta A. Lalwani, MD
Annual Meeting Talks
2018
Common Age-Related Macular Degeneration Genetic Risk Variants and Geographic Atrophy Lesion Growth in the Chroma and Spectri Phase 3 Lampalizumab Trials
Karl G. Csaky, MD, PhD
Annual Meeting Talks
2018
Randomized Trial Comparing Pneumatic Retinopexy vs Vitrectomy
Rajeev H. Muni, MD, MSC, FRCS(C), FASRS
Updates from the Field
2017

Category: Hereditary Retinal Disease & Genetics

See more